Becton, Dickinson and Company is an attractive firm that just made a good deal. Click here to find out why BDX stock is a Buy ...

Milford-based biotech company Waters Corp. will merge with Becton, Dickinson and Co.’s biosciences an diagnostic solutions ...

Shares of Waters Corp. WAT advanced 2.06% to $287.46 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.06% to 6,309.62 and ...

Waters Corp.'s $17.5B merger with BD Biosciences aims to double revenue but raises risks. Read here for an investment ...

Waters will pay Becton shareholders $4 billion in cash—raised through debt—and the remainder in stock. Waters shareholders ...

Waters Corp. closed 32.12% below its 52-week high of $423.56, which the company achieved on January 30th.

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Waters Corp. is paying $17.5B to merger with the biosciences unit of BD, doubling addressable market to $40B. However, ...

Any one of the majors will be thrilled to snap some of these brands because there’s very little organic growth in the ...

A deal for Becton Dickinson’s biosciences and diagnostic solutions unit puts Waters Corp. in a greater position to compete ...

Kirkland & Ellis advises Waters on $17.5B merger with Becton Dickinson, creating a diagnostics and life sciences leader.

Waters Corporation (NYSE:WAT) will hold its Q2 2025 financial results conference call on Monday, August 4th, 2025 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on ...